← Back to directory

Richard Sylvester

Researcher Next ID · RN-024378

Researcher · Medicine

English Institute of Sport

Manchester, Netherlands

Not currently recruitingFunding unknown
Works count
552
Citation count
59,308
H-index
106
i10-index
299

Research interests

Medicine
Bladder and Urothelial Cancer Treatments
Urinary and Genital Oncology Studies
Prostate Cancer Treatment and Research
Renal cell carcinoma treatment
Urinary Tract Infections Management

Publications

  • European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

    European Urology · 2021 · https://doi.org/10.1016/j.eururo.2021.08.010

  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

    European Urology · 2020 · 10.1016/j.eururo.2020.05.042

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

    European Urology · 2019 · https://doi.org/10.1016/j.eururo.2019.08.016

  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update

    European Urology · 2017 · 10.1016/j.eururo.2017.07.036

  • EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

    European Urology · 2016 · https://doi.org/10.1016/j.eururo.2016.05.041

  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

    European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.06.044

  • EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

    European Urology · 2013 · https://doi.org/10.1016/j.eururo.2013.06.003

  • EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update

    European Urology · 2011 · 10.1016/j.eururo.2011.03.017

  • Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

    Journal of Clinical Oncology · 2011 · 10.1200/jco.2011.37.3571

  • A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

    European Urology · 2010 · 10.1016/j.eururo.2010.12.013

  • An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

    European Urology · 2009 · 10.1016/j.eururo.2009.04.038

  • Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

    European Urology · 2009 · 10.1016/j.eururo.2009.06.028

  • EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

    European Urology · 2008 · 10.1016/j.eururo.2008.04.051

  • Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

    The Lancet · 2006 · 10.1016/s0140-6736(06)69121-6

  • Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

    European Urology · 2006 · 10.1016/j.eururo.2005.12.031

  • A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

    European Urology · 2006 · 10.1016/j.eururo.2006.11.013

  • A SINGLE IMMEDIATE POSTOPERATIVE INSTILLATION OF CHEMOTHERAPY DECREASES THE RISK OF RECURRENCE IN PATIENTS WITH STAGE Ta T1 BLADDER CANCER: A META-ANALYSIS OF PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALS

    The Journal of Urology · 2004 · 10.1097/01.ju.0000125486.92260.b2

  • Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined Analysis

    The Journal of Urology · 2004 · 10.1097/01.ju.0000110610.61545.ae

  • Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials

    The Journal of Urology · 2002 · 10.1016/s0022-5347(05)64273-5

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    New England Journal of Medicine · 2002 · 10.1056/nejmoa020191

  • Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma

    Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.08.121

  • Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

    European Urology · 2002 · 10.1016/s0302-2838(02)00068-4

  • Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

    The Lancet · 2001 · 10.1016/s0140-6736(01)06103-7

  • Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data

    Digital Access to Libraries · 1997 · 10.1016/s0140-6736(97)08165-8

  • WHO handbook for reporting results of cancer treatment

    Controlled Clinical Trials · 1980 · 10.1016/0197-2456(80)90009-4

Current projects

    No projects listed.